More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effects
Med Page Today
JANUARY 9, 2024
(MedPage Today) -- Men treated with androgen deprivation therapy (ADT) for prostate cancer had a significantly higher risk of dementia and other neurocognitive disorders, according to a meta-analysis of more than 2.5 million patients. The magnitude.
Let's personalize your content